Compare Stocks → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:ALHCNYSE:BHGNASDAQ:CLOVNASDAQ:INSM Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALHCAlignment Healthcare$6.78-1.3%$5.15$4.46▼$9.20$1.30B1.23920,305 shs1.64 million shsBHGBright Health Group$6.30+0.8%$6.75$4.94▼$82.40$50.29M0.9372,717 shs3,848 shsCLOVClover Health Investments$0.87+17.6%$0.74$0.61▼$1.63$431.20M1.888.50 million shs22.04 million shsINSMInsmed$26.00-0.3%$26.61$18.08▼$32.00$3.86B0.931.74 million shs1.85 million shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALHCAlignment Healthcare-1.31%+29.89%+41.25%+1.65%-8.50%BHGBright Health Group0.00%+2.44%-1.10%-9.22%-69.71%CLOVClover Health Investments+17.65%+35.44%+19.28%-12.94%-6.39%INSMInsmed-0.31%+1.60%-7.51%-9.00%+37.35%Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new reportMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALHCAlignment Healthcare3.0208 of 5 stars4.31.00.00.02.33.30.6BHGBright Health Group0.7064 of 5 stars2.50.00.00.02.71.70.0CLOVClover Health Investments1.839 of 5 stars3.01.00.00.02.73.30.6INSMInsmed4.1461 of 5 stars4.51.00.04.52.90.00.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALHCAlignment Healthcare2.56Moderate Buy$8.6928.24% UpsideBHGBright Health Group1.00Sell$13.00106.35% UpsideCLOVClover Health Investments2.00Hold$1.5072.29% UpsideINSMInsmed3.00Buy$44.9272.76% UpsideCurrent Analyst RatingsLatest ALHC, CLOV, BHG, and INSM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2024ALHCAlignment HealthcarePiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Overweight$6.00 ➝ $8.005/3/2024ALHCAlignment HealthcareStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$6.00 ➝ $7.004/23/2024ALHCAlignment HealthcareStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$11.00 ➝ $9.004/23/2024INSMInsmedTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$48.004/11/2024INSMInsmedBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$37.00 ➝ $40.004/1/2024INSMInsmedWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$55.003/6/2024ALHCAlignment HealthcareWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform3/6/2024ALHCAlignment HealthcareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageUnderweight$4.503/6/2024ALHCAlignment HealthcarePiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Neutral$12.00 ➝ $6.002/28/2024ALHCAlignment HealthcareUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$9.00 ➝ $8.502/27/2024INSMInsmedGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$52.00 ➝ $54.00(Data available from 5/9/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALHCAlignment Healthcare$1.82B0.71N/AN/A$0.84 per share8.07BHGBright Health Group$2.76B0.02N/AN/A($25.47) per share-0.25CLOVClover Health Investments$2.03B0.21N/AN/A$0.59 per share1.48INSMInsmed$305.21M12.66N/AN/A($2.32) per share-11.21Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALHCAlignment Healthcare-$148.02M-$0.84N/AN/AN/A-7.81%-91.06%-22.63%8/1/2024 (Estimated)BHGBright Health Group-$1.46B-$208.73N/AN/AN/A-85.40%N/A-10.26%N/ACLOVClover Health Investments-$213.36M-$0.45N/AN/AN/A-10.49%-62.58%-18.19%8/13/2024 (Estimated)INSMInsmed-$749.57M-$5.34N/AN/AN/A-245.59%N/A-53.34%5/9/2024 (Confirmed)Latest ALHC, CLOV, BHG, and INSM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2024N/AINSMInsmed-$1.21N/A+$1.21N/AN/AN/A 5/2/2024Q1 2024ALHCAlignment Healthcare-$0.24-$0.25-$0.01-$0.25$599.75 million$628.60 million 3/12/2024Q4 2023CLOVClover Health Investments-$0.18-$0.12+$0.06-$0.09$491.20 million$510.25 million2/27/2024Q4 2023ALHCAlignment Healthcare-$0.22-$0.25-$0.03-$0.25$444.56 million$465.39 million 2/22/202412/31/2023INSMInsmed-$1.13-$1.28-$0.15-$1.28$82.15 million$83.70 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALHCAlignment HealthcareN/AN/AN/AN/AN/ABHGBright Health GroupN/AN/AN/AN/AN/ACLOVClover Health InvestmentsN/AN/AN/AN/AN/AINSMInsmedN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALHCAlignment Healthcare1.231.571.57BHGBright Health GroupN/A1.041.04CLOVClover Health InvestmentsN/A1.641.64INSMInsmedN/A4.123.75OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALHCAlignment Healthcare86.19%BHGBright Health GroupN/ACLOVClover Health Investments19.77%INSMInsmedN/AInsider OwnershipCompanyInsider OwnershipALHCAlignment Healthcare6.30%BHGBright Health Group58.40%CLOVClover Health Investments21.82%INSMInsmed4.60%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableALHCAlignment Healthcare1,536191.20 million179.15 millionOptionableBHGBright Health Group2,8407.98 million3.32 millionNot OptionableCLOVClover Health Investments552495.29 million387.22 millionOptionableINSMInsmed373148.56 million141.72 millionOptionableALHC, CLOV, BHG, and INSM HeadlinesSourceHeadlineInsmed Reports First-Quarter 2024 Financial Results and Provides Business Updateprnewswire.com - May 9 at 7:00 AMStocks Slip Before the Open on Higher Bond Yields and Weak Earnings, BoE Decision in Focusmsn.com - May 9 at 6:46 AMHere's what to expect from Insmed's earningsmarkets.businessinsider.com - May 8 at 3:26 PMShould You Buy Insmed (INSM) Ahead of Earnings?zacks.com - May 8 at 11:21 AMWe Think Some Shareholders May Hesitate To Increase Insmed Incorporated's (NASDAQ:INSM) CEO Compensationfinance.yahoo.com - May 7 at 8:07 AMInsmed To Present at the BofA Securities Health Care Conference 2024prnewswire.com - May 7 at 8:00 AMInsmed (NASDAQ:INSM) Lowered to Sell at StockNews.comamericanbankingnews.com - May 7 at 6:54 AMInsmed (NASDAQ:INSM) Cut to "Sell" at StockNews.commarketbeat.com - May 7 at 12:44 AMInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)prnewswire.com - May 3 at 8:00 AMInsmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?zacks.com - May 2 at 11:06 AMInsmed (INSM) to Release Earnings on Thursdayamericanbankingnews.com - May 2 at 3:50 AMInsmed Incorporated (NASDAQ:INSM) Given Average Recommendation of "Buy" by Brokeragesamericanbankingnews.com - May 2 at 2:30 AMabrdn plc Buys New Shares in Insmed Incorporated (NASDAQ:INSM)marketbeat.com - April 29 at 5:16 AMJennison Associates LLC Makes New $3.75 Million Investment in Insmed Incorporated (NASDAQ:INSM)marketbeat.com - April 27 at 6:08 AMInsmed shares upgraded on growth potentialinvesting.com - April 25 at 5:59 PMInsmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024prnewswire.com - April 25 at 8:00 AMTruist Securities Initiates Coverage of Insmed (INSM) with Buy Recommendationmsn.com - April 24 at 3:19 AMInsmed gets grant for treatment of gram-positive pulmonary bacterial infectionspharmaceutical-technology.com - April 23 at 5:18 PMTruist Financial Begins Coverage on Insmed (NASDAQ:INSM)marketbeat.com - April 23 at 7:15 AMInsmed (NASDAQ:INSM) Sees Large Volume Increasemarketbeat.com - April 22 at 1:31 PMActress Jane Seymour on the Effects of “Unseenism” and the #1 Way To Fight It: “Health Is Everything”msn.com - April 20 at 10:28 AMKnights of Columbus Asset Advisors LLC Raises Stock Position in Insmed Incorporated (NASDAQ:INSM)marketbeat.com - April 19 at 1:38 PMAnalysts Offer Insights on Healthcare Companies: Insmed (INSM) and UnitedHealth (UNH)markets.businessinsider.com - April 16 at 8:04 PMBarclays Increases Insmed (NASDAQ:INSM) Price Target to $40.00marketbeat.com - April 11 at 10:33 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAlignment HealthcareNASDAQ:ALHCAlignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.Bright Health GroupNYSE:BHGBright Health Group, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, Bright HealthCare and Consumer Care. The Consumer Care segment delivers virtual and in-person clinical care services contracts through primary care clinics. It operates managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers medicare health plan products to consumers. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.Clover Health InvestmentsNASDAQ:CLOVClover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.InsmedNASDAQ:INSMInsmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is ARIKAYCE® (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. MAC lung disease is a rare and often chronic infection that can cause irreversible lung damage and can be fatal. Insmed's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.